Literature DB >> 28403511

Decrease in serum IL-32 level in patients with atopic dermatitis after cyclosporine treatment.

N Kitayama1, A Otsuka1, Y Nonomura1, C Nakashima1, T Honda1, K Kabashima1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28403511     DOI： 10.1111/jdv.14274

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

1.  IL-32 promotes the occurrence of atopic dermatitis by activating the JAK1/microRNA-155 axis.

Authors:  Jing Chang; Bin Zhou; Zhu Wei; Yongqi Luo
Journal:  J Transl Med       Date:  2022-05-11       Impact factor: 8.440

2.  Elevated Gene Expression of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Peripheral Blood of Chronic Psoriatic Patients.

Authors:  Hani A Al-Shobaili; Zafar Rasheed
Journal:  Diseases       Date:  2018-03-14

3.  Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis.

Authors:  Hani A Al-Shobaili; Jalees Farhan; Uzma Zafar; Zafar Rasheed
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun

4.  Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.

Authors:  Paola Di Benedetto; Giuliana Guggino; Giovanna Manzi; Piero Ruscitti; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Roberto Badagliacca; Valeria Riccieri; Carmine Dario Vizza; Ganna Radchenko; Vasiliki Liakouli; Francesco Ciccia; Paola Cipriani; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2020-06-01       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.